1. Home
  2. RLAY

as 11-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Founded: 2015 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 1.1B IPO Year: 2020
Target Price: $20.88 AVG Volume (30 days): 1.2M
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.61 EPS Growth: N/A
52 Week Low/High: $5.60 - $12.14 Next Earning Date: 11-06-2024
Revenue: $10,006,000 Revenue Growth: -61.22%
Revenue Growth (this year): -59.48% Revenue Growth (next year): -93.56%

RLAY Daily Stock ML Predictions

Stock Insider Trading Activity of Relay Therapeutics Inc. (RLAY)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Bergstrom Donald A RLAY President, R&D Oct 28 '24 Sell $6.06 2,688 $16,289.28 520,745
Adams Brian RLAY Chief Legal Officer Oct 28 '24 Sell $6.06 1,632 $9,889.92 321,907
Catinazzo Thomas RLAY Chief Financial Officer Oct 28 '24 Sell $6.02 9,102 $54,905.12 311,496
Bergstrom Donald A RLAY President, R&D Sep 27 '24 Sell $7.51 648 $4,866.48 520,745
Adams Brian RLAY Chief Legal Officer Sep 27 '24 Sell $7.51 295 $2,215.45 321,907
Catinazzo Thomas RLAY Chief Financial Officer Sep 27 '24 Sell $7.48 6,457 $48,183.97 311,496
Rahmer Peter RLAY See remarks Sep 27 '24 Sell $7.51 245 $1,839.95 391,684

Share on Social Networks: